Calla Lily Clinical Care

Drug Delivery · London, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of women-specific drug-delivery systems designed to improve patient outcomes. Calla Lily Clinical Care is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $14.4 million in Jan 2025. It has raised $6.9 million across 1 recorded round; the latest was an accelerator round in Mar 2025.

Last reported valuation
$14.4M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
Accelerator/Incubator
Mar 2025
How much has Calla Lily Clinical Care raised?
$6.9Macross 1 recorded rounds · Mar 2025 – Mar 2025

Most recently, Calla Lily Clinical Care raised an undisclosed amount in its Accelerator/Incubator (Mar 2025).

Free account
More of Calla Lily Clinical Care with a free account
  • ·Watch Calla Lily Clinical Care: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Calla Lily Clinical Care round by round

1 rounds
Mar 2025Accelerator/Incubatorundisclosed▮
+ 1 more investors · free account

How much has Calla Lily Clinical Care raised?

Calla Lily Clinical Care has raised $6.9 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Mar 2025.

Calla Lily Clinical Care investors

5 investors are on record for Calla Lily Clinical Care, including Innovate UK, Springboard Enterprises, Conduit Connect and HH Global Partners.

For fundraisers
Raising for a company like Calla Lily Clinical Care?

5 investors have backed Calla Lily Clinical Care — start your target list with the firms already writing checks in drug delivery.

See all 5 investors →

Frequently asked about Calla Lily Clinical Care

How much has Calla Lily Clinical Care raised?
Calla Lily Clinical Care has raised $6.9M in total across 1 recorded funding rounds.
When was Calla Lily Clinical Care's last funding round?
Calla Lily Clinical Care's most recent recorded round was Accelerator/Incubator in Mar 2025.